PMC:7074453 / 23378-24107 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"672","span":{"begin":53,"end":61},"obj":"Species"},{"id":"673","span":{"begin":62,"end":66},"obj":"Disease"},{"id":"674","span":{"begin":70,"end":78},"obj":"Disease"},{"id":"675","span":{"begin":137,"end":142},"obj":"Disease"},{"id":"676","span":{"begin":152,"end":157},"obj":"Disease"},{"id":"677","span":{"begin":167,"end":186},"obj":"Disease"},{"id":"678","span":{"begin":196,"end":216},"obj":"Disease"},{"id":"679","span":{"begin":226,"end":233},"obj":"Disease"},{"id":"680","span":{"begin":243,"end":250},"obj":"Disease"},{"id":"681","span":{"begin":260,"end":269},"obj":"Disease"},{"id":"682","span":{"begin":270,"end":278},"obj":"Disease"},{"id":"683","span":{"begin":295,"end":299},"obj":"Disease"},{"id":"684","span":{"begin":391,"end":403},"obj":"Disease"},{"id":"685","span":{"begin":413,"end":421},"obj":"Disease"},{"id":"686","span":{"begin":431,"end":453},"obj":"Disease"},{"id":"687","span":{"begin":463,"end":482},"obj":"Disease"},{"id":"688","span":{"begin":500,"end":510},"obj":"Disease"},{"id":"689","span":{"begin":524,"end":543},"obj":"Disease"}],"attributes":[{"id":"A672","pred":"tao:has_database_id","subj":"672","obj":"Tax:9606"},{"id":"A673","pred":"tao:has_database_id","subj":"673","obj":"MESH:D003643"},{"id":"A674","pred":"tao:has_database_id","subj":"674","obj":"MESH:C000657245"},{"id":"A675","pred":"tao:has_database_id","subj":"675","obj":"MESH:D005334"},{"id":"A676","pred":"tao:has_database_id","subj":"676","obj":"MESH:D003371"},{"id":"A677","pred":"tao:has_database_id","subj":"677","obj":"MESH:D004417"},{"id":"A678","pred":"tao:has_database_id","subj":"678","obj":"MESH:D002637"},{"id":"A679","pred":"tao:has_database_id","subj":"679","obj":"MESH:D005221"},{"id":"A680","pred":"tao:has_database_id","subj":"680","obj":"MESH:D004417"},{"id":"A681","pred":"tao:has_database_id","subj":"681","obj":"MESH:D004244"},{"id":"A682","pred":"tao:has_database_id","subj":"682","obj":"MESH:D006261"},{"id":"A683","pred":"tao:has_database_id","subj":"683","obj":"MESH:D010146"},{"id":"A684","pred":"tao:has_database_id","subj":"684","obj":"MESH:D006973"},{"id":"A685","pred":"tao:has_database_id","subj":"685","obj":"MESH:D003920"},{"id":"A686","pred":"tao:has_database_id","subj":"686","obj":"MESH:D003324"},{"id":"A687","pred":"tao:has_database_id","subj":"687","obj":"MESH:D002544"},{"id":"A688","pred":"tao:has_database_id","subj":"688","obj":"MESH:D001991"},{"id":"A689","pred":"tao:has_database_id","subj":"689","obj":"MESH:D010300"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Figure 2 Clinical symptoms and comorbidities of the patients died of COVID-19. (A) Among 41 cases with fatalities, the symptoms include fever (80.5%), cough (56.1%), shortness of breath (31.7%), chest tightness/pain (24.4%), fatigue (22.0%), dyspnea (12.2%), dizziness/headache (4.9%), general pain (7.3%), and chills (4.9%). (B) Among 26 cases with fatalities, the major comorbidities are hypertension (53.8%), diabetes (42.3%), coronary heart disease (19.2%), cerebral infarction (15.4%), chronic bronchitis (19.2%), and Parkinson’s disease (7.7%). The case information is from reports released by different provincial Health Commissions, including the National Health Commission (the links are shown in Supplementary Data 1)."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T65","span":{"begin":196,"end":201},"obj":"Body_part"},{"id":"T66","span":{"begin":440,"end":445},"obj":"Body_part"}],"attributes":[{"id":"A65","pred":"fma_id","subj":"T65","obj":"http://purl.org/sig/ont/fma/fma9576"},{"id":"A66","pred":"fma_id","subj":"T66","obj":"http://purl.org/sig/ont/fma/fma7088"}],"text":"Figure 2 Clinical symptoms and comorbidities of the patients died of COVID-19. (A) Among 41 cases with fatalities, the symptoms include fever (80.5%), cough (56.1%), shortness of breath (31.7%), chest tightness/pain (24.4%), fatigue (22.0%), dyspnea (12.2%), dizziness/headache (4.9%), general pain (7.3%), and chills (4.9%). (B) Among 26 cases with fatalities, the major comorbidities are hypertension (53.8%), diabetes (42.3%), coronary heart disease (19.2%), cerebral infarction (15.4%), chronic bronchitis (19.2%), and Parkinson’s disease (7.7%). The case information is from reports released by different provincial Health Commissions, including the National Health Commission (the links are shown in Supplementary Data 1)."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T43","span":{"begin":196,"end":201},"obj":"Body_part"},{"id":"T44","span":{"begin":440,"end":445},"obj":"Body_part"}],"attributes":[{"id":"A43","pred":"uberon_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/UBERON_0001443"},{"id":"A44","pred":"uberon_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"}],"text":"Figure 2 Clinical symptoms and comorbidities of the patients died of COVID-19. (A) Among 41 cases with fatalities, the symptoms include fever (80.5%), cough (56.1%), shortness of breath (31.7%), chest tightness/pain (24.4%), fatigue (22.0%), dyspnea (12.2%), dizziness/headache (4.9%), general pain (7.3%), and chills (4.9%). (B) Among 26 cases with fatalities, the major comorbidities are hypertension (53.8%), diabetes (42.3%), coronary heart disease (19.2%), cerebral infarction (15.4%), chronic bronchitis (19.2%), and Parkinson’s disease (7.7%). The case information is from reports released by different provincial Health Commissions, including the National Health Commission (the links are shown in Supplementary Data 1)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T143","span":{"begin":70,"end":78},"obj":"Disease"},{"id":"T144","span":{"begin":391,"end":403},"obj":"Disease"},{"id":"T145","span":{"begin":413,"end":421},"obj":"Disease"},{"id":"T146","span":{"begin":431,"end":453},"obj":"Disease"},{"id":"T147","span":{"begin":440,"end":453},"obj":"Disease"},{"id":"T148","span":{"begin":463,"end":482},"obj":"Disease"},{"id":"T152","span":{"begin":492,"end":510},"obj":"Disease"},{"id":"T153","span":{"begin":500,"end":510},"obj":"Disease"},{"id":"T154","span":{"begin":524,"end":543},"obj":"Disease"}],"attributes":[{"id":"A143","pred":"mondo_id","subj":"T143","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A144","pred":"mondo_id","subj":"T144","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"},{"id":"A145","pred":"mondo_id","subj":"T145","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A146","pred":"mondo_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/MONDO_0005010"},{"id":"A147","pred":"mondo_id","subj":"T147","obj":"http://purl.obolibrary.org/obo/MONDO_0005267"},{"id":"A148","pred":"mondo_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/MONDO_0002679"},{"id":"A149","pred":"mondo_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/MONDO_0005098"},{"id":"A150","pred":"mondo_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/MONDO_0011057"},{"id":"A151","pred":"mondo_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/MONDO_0020671"},{"id":"A152","pred":"mondo_id","subj":"T152","obj":"http://purl.obolibrary.org/obo/MONDO_0005607"},{"id":"A153","pred":"mondo_id","subj":"T153","obj":"http://purl.obolibrary.org/obo/MONDO_0003781"},{"id":"A154","pred":"mondo_id","subj":"T154","obj":"http://purl.obolibrary.org/obo/MONDO_0005180"}],"text":"Figure 2 Clinical symptoms and comorbidities of the patients died of COVID-19. (A) Among 41 cases with fatalities, the symptoms include fever (80.5%), cough (56.1%), shortness of breath (31.7%), chest tightness/pain (24.4%), fatigue (22.0%), dyspnea (12.2%), dizziness/headache (4.9%), general pain (7.3%), and chills (4.9%). (B) Among 26 cases with fatalities, the major comorbidities are hypertension (53.8%), diabetes (42.3%), coronary heart disease (19.2%), cerebral infarction (15.4%), chronic bronchitis (19.2%), and Parkinson’s disease (7.7%). The case information is from reports released by different provincial Health Commissions, including the National Health Commission (the links are shown in Supplementary Data 1)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T210","span":{"begin":81,"end":82},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T211","span":{"begin":90,"end":92},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"},{"id":"T212","span":{"begin":196,"end":201},"obj":"http://www.ebi.ac.uk/efo/EFO_0000965"},{"id":"T213","span":{"begin":328,"end":329},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T214","span":{"begin":440,"end":445},"obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"T215","span":{"begin":440,"end":445},"obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"T216","span":{"begin":440,"end":445},"obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"T217","span":{"begin":440,"end":445},"obj":"http://www.ebi.ac.uk/efo/EFO_0000815"}],"text":"Figure 2 Clinical symptoms and comorbidities of the patients died of COVID-19. (A) Among 41 cases with fatalities, the symptoms include fever (80.5%), cough (56.1%), shortness of breath (31.7%), chest tightness/pain (24.4%), fatigue (22.0%), dyspnea (12.2%), dizziness/headache (4.9%), general pain (7.3%), and chills (4.9%). (B) Among 26 cases with fatalities, the major comorbidities are hypertension (53.8%), diabetes (42.3%), coronary heart disease (19.2%), cerebral infarction (15.4%), chronic bronchitis (19.2%), and Parkinson’s disease (7.7%). The case information is from reports released by different provincial Health Commissions, including the National Health Commission (the links are shown in Supplementary Data 1)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T182","span":{"begin":0,"end":551},"obj":"Sentence"},{"id":"T183","span":{"begin":552,"end":729},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Figure 2 Clinical symptoms and comorbidities of the patients died of COVID-19. (A) Among 41 cases with fatalities, the symptoms include fever (80.5%), cough (56.1%), shortness of breath (31.7%), chest tightness/pain (24.4%), fatigue (22.0%), dyspnea (12.2%), dizziness/headache (4.9%), general pain (7.3%), and chills (4.9%). (B) Among 26 cases with fatalities, the major comorbidities are hypertension (53.8%), diabetes (42.3%), coronary heart disease (19.2%), cerebral infarction (15.4%), chronic bronchitis (19.2%), and Parkinson’s disease (7.7%). The case information is from reports released by different provincial Health Commissions, including the National Health Commission (the links are shown in Supplementary Data 1)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T85","span":{"begin":137,"end":142},"obj":"Phenotype"},{"id":"T86","span":{"begin":152,"end":157},"obj":"Phenotype"},{"id":"T87","span":{"begin":167,"end":186},"obj":"Phenotype"},{"id":"T88","span":{"begin":196,"end":211},"obj":"Phenotype"},{"id":"T89","span":{"begin":212,"end":216},"obj":"Phenotype"},{"id":"T90","span":{"begin":226,"end":233},"obj":"Phenotype"},{"id":"T91","span":{"begin":243,"end":250},"obj":"Phenotype"},{"id":"T92","span":{"begin":260,"end":269},"obj":"Phenotype"},{"id":"T93","span":{"begin":270,"end":278},"obj":"Phenotype"},{"id":"T94","span":{"begin":295,"end":299},"obj":"Phenotype"},{"id":"T95","span":{"begin":312,"end":318},"obj":"Phenotype"},{"id":"T96","span":{"begin":391,"end":403},"obj":"Phenotype"},{"id":"T97","span":{"begin":492,"end":510},"obj":"Phenotype"}],"attributes":[{"id":"A85","pred":"hp_id","subj":"T85","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A86","pred":"hp_id","subj":"T86","obj":"http://purl.obolibrary.org/obo/HP_0012735"},{"id":"A87","pred":"hp_id","subj":"T87","obj":"http://purl.obolibrary.org/obo/HP_0002098"},{"id":"A88","pred":"hp_id","subj":"T88","obj":"http://purl.obolibrary.org/obo/HP_0031352"},{"id":"A89","pred":"hp_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/HP_0012531"},{"id":"A90","pred":"hp_id","subj":"T90","obj":"http://purl.obolibrary.org/obo/HP_0012378"},{"id":"A91","pred":"hp_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/HP_0002094"},{"id":"A92","pred":"hp_id","subj":"T92","obj":"http://purl.obolibrary.org/obo/HP_0002321"},{"id":"A93","pred":"hp_id","subj":"T93","obj":"http://purl.obolibrary.org/obo/HP_0002315"},{"id":"A94","pred":"hp_id","subj":"T94","obj":"http://purl.obolibrary.org/obo/HP_0012531"},{"id":"A95","pred":"hp_id","subj":"T95","obj":"http://purl.obolibrary.org/obo/HP_0025143"},{"id":"A96","pred":"hp_id","subj":"T96","obj":"http://purl.obolibrary.org/obo/HP_0000822"},{"id":"A97","pred":"hp_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/HP_0004469"}],"text":"Figure 2 Clinical symptoms and comorbidities of the patients died of COVID-19. (A) Among 41 cases with fatalities, the symptoms include fever (80.5%), cough (56.1%), shortness of breath (31.7%), chest tightness/pain (24.4%), fatigue (22.0%), dyspnea (12.2%), dizziness/headache (4.9%), general pain (7.3%), and chills (4.9%). (B) Among 26 cases with fatalities, the major comorbidities are hypertension (53.8%), diabetes (42.3%), coronary heart disease (19.2%), cerebral infarction (15.4%), chronic bronchitis (19.2%), and Parkinson’s disease (7.7%). The case information is from reports released by different provincial Health Commissions, including the National Health Commission (the links are shown in Supplementary Data 1)."}